Glass for medicine container and glass tube for medicine container
US-2024018033-A1 · Jan 18, 2024 · US
Pharmaceutical container, method for manufacturing pharmaceutical container, and coating agent
US12478554B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12478554-B2 |
| Application number | US-202117908993-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 8, 2021 |
| Priority date | Mar 9, 2020 |
| Publication date | Nov 25, 2025 |
| Grant date | Nov 25, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A pharmaceutical container of the present invention is a pharmaceutical container including at least a container and a coating layer, and is characterized that the coating layer is coated on at least an inner surface of the container and the coating layer contains a silicone-based resin.
First claim
Opening claim text (preview).
The invention claimed is: 1 . A pharmaceutical container comprising at least a container and a coating layer, wherein the coating layer is formed on at least an inner surface of the container, and the coating layer contains a silicone-based resin, wherein the silicone-based resin contains dimethylpolysiloxane, phenylpolysiloxane, and methylpolysiloxane, and dimethylpolysiloxane:phenylpolysiloxane:methylpolysiloxane=A:B:C are in a molar ratio, A is 0.1 to 4.0, B is 0.1 to 4.0, and C is 0.1 to 4.0. 2 . The pharmaceutical container according to claim 1 , wherein the coating layer is substantially free of a halogen component. 3 . The pharmaceutical container according to claim 1 , wherein the coating layer has a thickness of 10 to 2500 nm. 4 . The pharmaceutical container according to claim 1 , wherein the container is made of silicate glass, and the silicate glass contains, by mass, 65 to 85% of SiO 2 , 0 to 15% of Al 2 O 3 , 0 to 13% of B 2 O 3 , 0 to 5% of Li 2 O, 3 to 15% of Na 2 O, 0 to 5% of K 2 O, 0 to 5% of MgO, 0 to 15% of CaO, and 0 to 5% of BaO as a glass composition.
Assignees
Inventors
Classifications
Polysiloxanes · CPC title
Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced {(electrically insulating plastics, resins or waxes H01B3/30)}; Filling pastes · CPC title
Siloxanes having aromatic substituents, e.g. phenyl side groups · CPC title
Polysiloxanes · CPC title
After-treatment · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12478554B2 cover?
- A pharmaceutical container of the present invention is a pharmaceutical container including at least a container and a coating layer, and is characterized that the coating layer is coated on at least an inner surface of the container and the coating layer contains a silicone-based resin.
- Who is the assignee on this patent?
- Nippon Electric Glass Co
- What technology area does this patent fall under?
- Primary CPC classification C03C3/118. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).